Skip to main content

Commercial launch of the Antibiofilmogram® BST Staph®

By 17 May 2021May 6th, 2022No Comments

On December 15th, 2020, BioFilm Control announces the next commercial launch of the Antibiofilmogram® BST Staph®: Biofilm Susceptibility Testing, the first test evaluating BioFilm with clinical utility.

With the Antibiofilmogram®, bacteriology enters a new “post-antibiogram” era, where the cure of chronic bacterial infections will target not only the germ but also its biofilm.


Access the press release

Contact us: